PPD’s AES Acquires Global Site Business from Bioclinica


Applied Clinical Trials

Accelerated Enrollment Solutions, a business unit of Pharmaceutical Product Development, LLC, has acquired the clinical research site business of Bioclinica. This  acquisition now expands AES’ global footprint in patient access and site conduct across five continents, 20 countries, over 180 research sites and more than 100 million households.

For more information, click here. 

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
Related Content
© 2024 MJH Life Sciences

All rights reserved.